IMAGGS: a radiogenomic framework for identifying multi-way associations in breast cancer subtypes

• Published in: Journal of genetics and genomics Vol. 51; no. 4; pp. 443 - 453
• Main Authors: Liang, Shuyu, Xu, Sicheng, Zhou, Shichong, Chang, Cai, Shao, Zhiming, Wang, Yuanyuan, Chen, Sheng, Huang, Yunxia, Guo, Yi
• Format: Journal Article
• Language: English
• Published: China Elsevier Ltd 01.04.2024
• Subjects: Breast cancer; IMAGGS; Molecular subtypes; Radiogenomic framework; “Image–gene–gene set” associations; Molecular subtypes; Breast cancer; IMAGGS; Radiogenomic framework; “Image–gene–gene set” associations
• ISSN: 1673-8527
• DOI: 10.1016/j.jgg.2023.09.010

Investigating correlations between radiomic and genomic profiling in breast cancer (BC) molecular subtypes is crucial for understanding disease mechanisms and providing personalized treatment. We present a well-designed radiogenomic framework image–gene–gene set (IMAGGS), which detects multi-way associations in BC subtypes by integrating radiomic and genomic features. Our dataset consists of 721 patients, each of whom has 12 ultrasound (US) images captured from different angles and gene mutation data. To better characterize tumor traits, 12 multi-angle US images are fused using two distinct strategies. Then, we analyze complex many-to-many associations between phenotypic and genotypic features using a machine learning algorithm, deviating from the prevalent one-to-one relationship pattern observed in previous studies. Key radiomic and genomic features are screened using these associations. In addition, gene set enrichment analysis is performed to investigate the joint effects of gene sets and delve deeper into the biological functions of BC subtypes. We further validate the feasibility of IMAGGS in a glioblastoma multiforme dataset to demonstrate the scalability of IMAGGS across different modalities and diseases. Taken together, IMAGGS provides a comprehensive characterization for diseases by associating imaging, genes, and gene sets, paving the way for biological interpretation of radiomics and development of targeted therapy. [Display omitted]